244 related articles for article (PubMed ID: 23424641)
1. Myotonia congenita mutation enhances the degradation of human CLC-1 chloride channels.
Lee TT; Zhang XD; Chuang CC; Chen JJ; Chen YA; Chen SC; Chen TY; Tang CY
PLoS One; 2013; 8(2):e55930. PubMed ID: 23424641
[TBL] [Abstract][Full Text] [Related]
2. ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.
Imbrici P; Maggi L; Mangiatordi GF; Dinardo MM; Altamura C; Brugnoni R; Alberga D; Pinter GL; Ricci G; Siciliano G; Micheli R; Annicchiarico G; Lattanzi G; Nicolotti O; Morandi L; Bernasconi P; Desaphy JF; Mantegazza R; Camerino DC
J Physiol; 2015 Sep; 593(18):4181-99. PubMed ID: 26096614
[TBL] [Abstract][Full Text] [Related]
3. Physiology and pathophysiology of CLC-1: mechanisms of a chloride channel disease, myotonia.
Tang CY; Chen TY
J Biomed Biotechnol; 2011; 2011():685328. PubMed ID: 22187529
[TBL] [Abstract][Full Text] [Related]
4. The Cullin 4A/B-DDB1-Cereblon E3 Ubiquitin Ligase Complex Mediates the Degradation of CLC-1 Chloride Channels.
Chen YA; Peng YJ; Hu MC; Huang JJ; Chien YC; Wu JT; Chen TY; Tang CY
Sci Rep; 2015 May; 5():10667. PubMed ID: 26021757
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inverted activation of ClC-1 channels caused by a novel myotonia congenita mutation.
Zhang J; Sanguinetti MC; Kwiecinski H; Ptácek LJ
J Biol Chem; 2000 Jan; 275(4):2999-3005. PubMed ID: 10644771
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes.
Desaphy JF; Gramegna G; Altamura C; Dinardo MM; Imbrici P; George AL; Modoni A; Lomonaco M; Conte Camerino D
Exp Neurol; 2013 Oct; 248():530-40. PubMed ID: 23933576
[TBL] [Abstract][Full Text] [Related]
7. Dominantly inherited myotonia congenita resulting from a mutation that increases open probability of the muscle chloride channel CLC-1.
Richman DP; Yu Y; Lee TT; Tseng PY; Yu WP; Maselli RA; Tang CY; Chen TY
Neuromolecular Med; 2012 Dec; 14(4):328-37. PubMed ID: 22790975
[TBL] [Abstract][Full Text] [Related]
8. A CLCN1 mutation in dominant myotonia congenita impairs the increment of chloride conductance during repetitive depolarization.
Tsujino A; Kaibara M; Hayashi H; Eguchi H; Nakayama S; Sato K; Fukuda T; Tateishi Y; Shirabe S; Taniyama K; Kawakami A
Neurosci Lett; 2011 Apr; 494(2):155-60. PubMed ID: 21385601
[TBL] [Abstract][Full Text] [Related]
9. ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence.
Kubisch C; Schmidt-Rose T; Fontaine B; Bretag AH; Jentsch TJ
Hum Mol Genet; 1998 Oct; 7(11):1753-60. PubMed ID: 9736777
[TBL] [Abstract][Full Text] [Related]
10. Defective Gating and Proteostasis of Human ClC-1 Chloride Channel: Molecular Pathophysiology of Myotonia Congenita.
Jeng CJ; Fu SJ; You CY; Peng YJ; Hsiao CT; Chen TY; Tang CY
Front Neurol; 2020; 11():76. PubMed ID: 32117034
[TBL] [Abstract][Full Text] [Related]
11. Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita.
Altamura C; Conte E; Campanale C; Laghetti P; Saltarella I; Camerino GM; Imbrici P; Desaphy JF
Front Pharmacol; 2022; 13():958196. PubMed ID: 36034862
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90β.
Peng YJ; Huang JJ; Wu HH; Hsieh HY; Wu CY; Chen SC; Chen TY; Tang CY
Sci Rep; 2016 Sep; 6():32444. PubMed ID: 27580824
[TBL] [Abstract][Full Text] [Related]
13. The myotonia congenita mutation A331T confers a novel hyperpolarization-activated gate to the muscle chloride channel ClC-1.
Warnstedt M; Sun C; Poser B; Escriva MJ; Tranebjaerg L; Torbergsen T; van Ghelue M; Fahlke C
J Neurosci; 2002 Sep; 22(17):7462-70. PubMed ID: 12196568
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita.
Zhang J; Bendahhou S; Sanguinetti MC; Ptácek LJ
Neurology; 2000 Feb; 54(4):937-42. PubMed ID: 10690989
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.
Imbrici P; Altamura C; Camerino GM; Mangiatordi GF; Conte E; Maggi L; Brugnoni R; Musaraj K; Caloiero R; Alberga D; Marsano RM; Ricci G; Siciliano G; Nicolotti O; Mora M; Bernasconi P; Desaphy JF; Mantegazza R; Camerino DC
FASEB J; 2016 Oct; 30(10):3285-3295. PubMed ID: 27324117
[TBL] [Abstract][Full Text] [Related]
16. CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel.
Skálová D; Zídková J; Voháňka S; Mazanec R; Mušová Z; Vondráček P; Mrázová L; Kraus J; Réblová K; Fajkusová L
PLoS One; 2013; 8(12):e82549. PubMed ID: 24349310
[TBL] [Abstract][Full Text] [Related]
17. Multimeric structure of ClC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen).
Steinmeyer K; Lorenz C; Pusch M; Koch MC; Jentsch TJ
EMBO J; 1994 Feb; 13(4):737-43. PubMed ID: 8112288
[TBL] [Abstract][Full Text] [Related]
18. Myotonia congenita.
Lossin C; George AL
Adv Genet; 2008; 63():25-55. PubMed ID: 19185184
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological characteristics of R47W and A298T mutations in CLC-1 of myotonia congenita patients and evaluation of clinical features.
Chin HJ; Kim CH; Ha K; Shin JH; Kim DS; So I
Korean J Physiol Pharmacol; 2017 Jul; 21(4):439-447. PubMed ID: 28706458
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of ion conduction in ClC-type chloride channels: lessons from disease-causing mutations.
Fahlke C
Kidney Int; 2000 Mar; 57(3):780-6. PubMed ID: 10720929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
